Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

12

Number of overlapping holdings

48.0%

% of BBH's 27 holdings also in PBE

42.9%

% of PBE's 28 holdings also in BBH

Overlap by Weight
Sector Drift (BBH minus PBE)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in BBH
Weight
in PBE
Overlap
GILEAD SCIENCES INC 14.1% 6.7% 6.7%
AMGEN INC 18.3% 5.7% 5.7%
REGENERON PHARMACEUTICALS 6.2% 4.9% 4.9%
NATERA INC 3.8% 4.4% 3.8%
BIOGEN IDEC INC 3.2% 4.9% 3.2%

Position Highlights (Non-Overlapping Exposures)
BBH Overweight Relative to PBE
AMGEN INC 12.5%
VERTEX PHARMACEUTICALS INC 12.0%
GILEAD SCIENCES INC 7.4%
ARGENX SE ADR 4.9%
IQVIA HOLDINGS INC 4.3%
ALNYLAM PHARMACEUTICALS INC 3.7%
ICON PLC 3.1%
BIONTECH SE SPONSORED ADR 2.4%
BEIGENE LTD. SPONSORED ADR 2.3%
INSMED INC 2.1%
BBH Underweight Relative to PBE
UNITED THERAPEUTICS CORP -4.5%
HALOZYME THERAPEUTICS INC -3.6%
AXSOME THERAPEUTICS, INC. -3.6%
ROYALTY PHARMA PLC CLASS A -3.5%
INCYTE CORP -3.4%
TG THERAPEUTICS INC -3.1%
ACADIA PHARMACEUTICALS INC -3.0%
EXELIXIS INC -3.0%
BIOCRYST PHARMACEUTICALS INC -3.0%
CATALYST PHARMACEUTICAL PART -2.9%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY